Apploi Announces Partnership with CentralReach, ABA Therapy Software and Services Provider

NEW YORK, March 13, 2025 /PRNewswire/ — Apploi, the leading workforce platform for healthcare employers, is excited to announce a new partnership with CentralReach, the foremost provider of Autism and IDD Care software for ABA, multidisciplinary, and special education.

“We are thrilled to partner with CentralReach to offer their valued customers healthcare-focused hiring solutions to keep up with ever-rising ABA industry demands,” said Adam Lewis, CEO of Apploi. “This alliance is a prime example of how Apploi is dedicated to supporting employers through every step of the staffing process, so their providers and patients prosper.”

Apploi’s all-in-one platform allows users to hire, onboard, and schedule top autism and IDD care talent, enabling providers to allocate more time on delivering quality patient care by significantly reducing the time required to:

  • Find qualified candidates: Customers can find more qualified autism and IDD care candidates faster by uploading jobs once through the platform and automatically promoting the listings to dozens of top job boards, including Indeed, LinkedIn, and ZipRecruiter.
  • Complete the hiring cycle: Users can decrease time-to-hire by screening candidates and keeping them thoroughly engaged throughout the hiring process with unlimited, automated texts or emails.
  • Onboard effortlessly: Once a new hire is selected, users can easily onboard hires and get them on the schedule through the platform with digital onboarding packets, license verification, and shift management.

CentralReach COO, Clark Convery added, “Partnering with Apploi creates a comprehensive experience for our customers, from therapist recruitment through patient management. This is a critical time for hiring managers in the ABA industry—we’re happy to offer CentralReach customers an efficient, easy way to attract and retain urgently-needed therapists with Apploi’s market-leading platform.”

About CentralReach

CentralReach is the leading provider of autism and IDD care software, providing the only complete, end-to-end software and services platform that helps children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD) – and those who serve them – unlock potential, achieve better outcomes, and live more independent lives. With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting.

Trusted by more than 185,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit CentralReach.com or follow us on LinkedIn and Facebook.

About Apploi

Apploi is helping healthcare facilities stabilize their workforce and increase occupancy in the midst of a labor shortage with an all-in-one platform built to hire, onboard, and schedule top healthcare talent.

Working with over 9,000 healthcare organizations across the United States, the NYC-based tech company helps leaders solve the industry’s most pressing problem: how to provide superb care with few workers and more turnover. With the Apploi platform, facilities can manage the staff experience from job post through shift fulfillment – empowering teams to fill roles quicker, lessen agency dependence, and increase occupancy rates. To learn more about Apploi, visit apploi.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/apploi-announces-partnership-with-centralreach-aba-therapy-software-and-services-provider-302401351.html

SOURCE Apploi

Staff

Recent Posts

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

30 minutes ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

1 hour ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

1 hour ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

1 hour ago

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

23 hours ago